FREDUN.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
FREDUN.BOFredun Pharmaceuticals Limited	$1221.60	-7.81%	$20.2B	—
ANUHPHR.BOAnuh Pharma Limited	$89.42	-0.81%	$9.0B	—
BPLPHARMA.BOBharat Parenterals Limited	$1517.05	-2.13%	$10.5B	—
JENBURPH.BOJenburkt Pharmaceuticals Limited	$995.35	+1.15%	$4.4B	—
KOPRAN.BOKopran Limited	$260.60	+4.39%	$12.6B	—
KPL.BOKwality Pharmaceuticals Limited	$3348.05	-2.81%	$34.7B	—
PRAVEG.BOPraveg Ltd.	$253.15	-0.88%	$6.6B	—

Source: Financial Modeling Prep · peers by sector/industry

Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals Ltd. specializes in the development, manufacturing, and commercialization of a diverse range of products, including pharmaceuticals, nutraceuticals, and various herbal and dietary supplements for human consumption, alongside its animal healthcare portfolio. Nariman Bamansha Medhora established the company on June 8, 1987, and its main operations are conducted from Mumbai, India.

www.fredungroup.com

Employees: 736
IPO / List date: Dec 30, 2024
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds FREDUN.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in FREDUN.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded FREDUN.BO yet.